The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Abstract
OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement.”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [1]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484
Self-citationRisk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Self-citationPredictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347
Self-citation
Research works printed but not linked: 2
- Fahn S, 1987, Recent Development in Parkinson's Disease, 153
- 1987, Diagnostic and Statistical Manual of Mental Disorders
Cited by
Sorted by citations
Items 501–600 of 807
de Oliveira, G. S. R., Bressan, L., Balarini, F. B., Silva, R. S. J. E., Brito, M. M. C. M., Foss, M. P., Santos‐Lobato, B. L., & Tumas, V. (2020) · Dementia & Neuropsychologia · doi:10.1590/1980-57642020dn14-020011 · Cited by 9
The pathology of hallucinations: one or several points of processing breakdown?
Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2014) · doi:10.1002/9781118892794.ch12 · Cited by 9
Approaches for treating neuropsychiatric symptoms in Parkinson’s disease: a narrative review
Rodríguez-Antigüedad, J., Olmedo‐Saura, G., Pagonabarraga, J., Martínez‐Horta, S., & Kulisevsky, J. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251336903 · Cited by 8
The Impact of Sex‐Specific Survival on the Incidence of Dementia in Parkinson's Disease
Fink, A., Dodel, R. C., Georges, D., & Doblhammer, G. (2023) · Movement Disorders · doi:10.1002/mds.29596 · Cited by 8
Orepić, P., Bernasconi, F., Faggella, M., Faivre, N., & Blanke, O. (2023) · Psychological Medicine · doi:10.1017/s0033291723002222 · Cited by 7
Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin
Lyons, K. E., Pahwa, R., Hermanowicz, N. S., Davis, T. L., Pagán, F., & Isaacson, S. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1623669 · Cited by 8
Ciobanu, A. M., Ioniţă, I., Buleandră, M., David, I. G., Popa, D. E., Ciucu, A. A., & Budișteanu, M. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10443 · Cited by 8
Psychosis in Parkinson's disease in a Southeast Asian cohort: prevalence and clinical correlates
Mok, V. W. L., Chan, L. G., Goh, J. C. B., & Tan, L. C. S. (2021) · Singapore Medical Journal · doi:10.11622/smedj.2021182 · Cited by 8
Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson’s Disease
Gibson, L. L., Pollak, T. A., Heslegrave, A., Hye, A., Batzu, L., Rota, S., Trivedi, D., Nicholson, T. R., Ffytche, D. H., Zetterberg, H., et al. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223182 · Cited by 8
Self-citationHarvey, J., Smith, A. R., Weymouth, L. S., Smith, R. G., Castanho, I., Hubbard, L., Creese, B., Bresner, C., Williams, N. M., Pishva, E., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00877-5 · Cited by 9
Psychiatric Issues in Parkinson's Disease
Weintraub, D. A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00013-1 · Cited by 8
Dementia, depression and parkinsonism: A frequent association in the elderly
Polidori, M. C., Menculini, G., Senin, U., & Mecocci, P. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3606 · Cited by 8
Psychiatric issues in non-Alzheimer dementias
Aarsland, D., & Ballard, C. G. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.006 · Cited by 8
Self-citationGupta, S., Fiertag, O., & Warner, J. P. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.003558 · Cited by 11
Exploring Virtual Reality for the Assessment and Rehabilitation of Executive Functions
Pedroli, E., Serino, S., Pallavicini, F., Cipresso, P., & Riva, G. (2018) · International Journal of Virtual and Augmented Reality · doi:10.4018/ijvar.2018010103 · Cited by 8
Diniz, J. D. F. G., Silva, A. C., & Nóbrega, A. C. (2018) · International Journal of Language & Communication Disorders · doi:10.1111/1460-6984.12395 · Cited by 8
Imran, S., Patel, R. S., Onyeaka, H., Tahir, M., Madireddy, S., Mainali, P., Hossain, S., Rashid, W., Queeneth, U., & Ahmad, N. (2019) · Cureus · doi:10.7759/cureus.5227 · Cited by 8
MANAGEMENT OF PSYCHOSIS IN PARKINSON'S DISEASE
D'Souza, C., Gupta, A., Alldrick, M., & Sastry, B. S. D. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10488.x · Cited by 8
Prevalence, Incidence, and Risk Factors for Dementia in Parkinson's Disease
Levy, G., & Marder, K. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-326-2_20 · Cited by 8
Eversfield, C. L., & Orton, L. D. (2018) · doi:10.31219/osf.io/spjd7 · Cited by 8
A Comparison of Cognitive and Functional Care Differences in Four Long-term Care Settings
ASHCRAFT, A., OWEN, D., & FENG, D. (2006) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.10.005 · Cited by 8
Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease
Vaughan, C. P., Morley, J. F., Lehosit, J. B., McGwin, G., Muirhead, L., Khakharia, A., Johnson, T. M., Evatt, M. L., Sergent, T., Burgio, K. L., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1904 · Cited by 7
The effect of acetic acid-induced pain in Parkinson’s disease model in zebrafish
Cansız, D., Ünal, İ., Beler, M., Üstündağ, Ü. V., Ak, E. Ç., Emekli‐Alturfan, E., & Alturfan, A. A. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.09.004 · Cited by 7
Parkinson-Krankheit und Psychosen
Bizzarri, J. V., Giupponi, G., Maniscalco, I., Schroffenegger, P., Conca, A., & Kapfhammer, H. (2015) · Neuropsychiatrie · doi:10.1007/s40211-014-0132-8 · Cited by 7
Cognitive Problems in Parkinson Disease: Perspectives and Priorities of Patients and Care Partners
Raein, K. L., Ortiz-Hernández, S., & Benge, J. F. (2019) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000184 · Cited by 7
Parkinson’s Disease and Sleep/Wake Disturbances
Swick, T. J., & Ondo, W. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-46437-4_7 · Cited by 7
The role of attentional control over interference in minor hallucinations in Parkinson’s disease
Bejr‐Kasem, H., Martínez‐Horta, S., Pagonabarraga, J., Marín‐Lahoz, J., Horta‐Barba, A., Sampedro, F., Aracil‐Bolaños, I., Pérez‐Pérez, J., Campolongo, A., Izquierdo, C., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.07.009 · Cited by 7
Rajagopalan, K., Rashid, N., & Doshi, D. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2220597 · Cited by 7
Real or imagined: We need a new scale for psychosis in Parkinson's disease
Pontone, G. M., Mills, K. A., Dobkin, R. D., Hinkle, J. T., Nirenberg, M. J., & Schneider, R. B. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106004 · Cited by 7
Disorders of mood and affect in Parkinson's disease
Weintraub, D. A., & Stern, M. B. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83019-3 · Cited by 7
Nonmotor symptoms in Parkinson's disease: classification and management
Erro, R., Santangelo, G., Barone, P., & Vitale, C. (2015) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s44382 · Cited by 8
Fujishiro, H., Umegaki, H., Suzuki, Y., Isojima, D., Akatsu, H., Ikari, H., Iguchi, A., & Kosaka, K. (2007) · Psychogeriatrics · doi:10.1111/j.1479-8301.2007.00165.x · Cited by 7
Effects of rotigotine transdermal system on non-motor symptoms in Parkinson’s disease: an overview
Zesiewicz, T., & Martínez‐Martín, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.859986 · Cited by 7
Organische psychische Störungen
Wetterling, T. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57532-7_4 · Cited by 7
Reaching Those Most in Need – A Call to Action for Advanced Parkinson’s Disease
Agarwal, S., & Fleisher, J. E. (2016) · European Neurological Review · doi:10.17925/enr.2016.11.01.20 · Cited by 7
Proton Magnetic Resonance Spectroscopy Changes in Parkinson’s Disease With and Without Psychosis
Rodríguez‐Violante, M., Cervantes‐Arriaga, A., González-Latapí, P., León-Ortíz, P., de la Fuente‐Sandoval, C., & Corona, T. (2015) · Revista de investigaci�n Cl�nica · doi:10.1016/s0034-8376(25)00242-6 · Cited by 7
Psychiatric and cognitive disorders in Parkinson’s disease
Nilsson, F. M. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200405000-00008 · Cited by 7
Quetiapine Use in a Patient with Chronic Schizophrenia and Severe Parkinsonism
Stoner, S. C., Lea, J. W., Wolf, A. L., & Berges, A. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.11.1651 · Cited by 7
Epidemiology of Psychiatric Symptoms in Parkinson’s Disease
Leentjens, A. F. G. (2012) · Advances in biological psychiatry · doi:10.1159/000331522 · Cited by 7
MEDICAL TREATMENT OF MOTOR AND NONMOTOR FEATURES OF PARKINSON'S DISEASE
Zesiewicz, T. A., & Hauser, R. A. (2007) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000284567.94851.c5 · Cited by 7
Visual hallucinations in Parkinson's disease are associated with deficits in social perception
Albert, L., Vehar, N., Potheegadoo, J., Bernasconi, F., & Blanke, O. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251336196 · Cited by 5
Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson’s Disease
Zarkali, A., Lees, A. J., & Weil, R. S. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191635 · Cited by 6
Place of death in Parkinson’s disease: trends in the USA
Kumar, P., Yasmin, F., Khan, M. S., Shahid, I., Diwan, M. N., Leiter, R. E., & Warraich, H. J. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2021-003016 · Cited by 6
Cognitive Syndromes Associated With Movement Disorders
Goldman, J. G., & Holden, S. K. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001134 · Cited by 6
Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
Jeyadevan, A., Bakeberg, M. C., Byrnes, M. L., Kenna, J. E., McGregor, S., Ghosh, S., Horne, M. K., Stell, R., Evans, T., Mastaglia, F. L., et al. (2023) · Quality of Life Research · doi:10.1007/s11136-022-03321-w · Cited by 6
Laurent, L. C., Koskas, P., Estrada, J., Sebbagh, M., Lacaille, S., Raynaud-Simon, A., & Lilamand, M. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03776-7 · Cited by 6
Rajagopalan, K., Rashid, N., & Doshi, D. (2023) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2023-0114 · Cited by 6
Clinical management of Parkinson's disease dementia: pitfalls and progress
Samuel, M., Maidment, I. D., Boustani, M. A., & Fox, C. (2006) · Advances in Psychiatric Treatment · doi:10.1192/apt.12.2.121 · Cited by 6
Non-motor Symptoms in Parkinson’s Disease
Vuletić, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-38606-1_9 · Cited by 6
Tube feeding: Prolonging life or death in vulnerable populations?
Amella, E. J., Lawrence, J. F., & Gresle, S. O. (2005) · Mortality · doi:10.1080/13576270500031089 · Cited by 6
The Dopaminergic and Non‐Dopaminergic Features of Parkinson's Disease
Olanow, C. W., Stocchi, F., & Lang, A. E. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch1 · Cited by 6
Hsu, Y. (2009) · UA Campus Repository (The University of Arizona) · Cited by 6
Stampacchia, S., Bernasconi, F., Van De Ville, D., Amico, E., Pagonabarraga, J., Kulisevsky, J., & Blanke, O. (2025) · doi:10.1101/2025.04.17.649310 · Cited by 5
Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies
Gibson, L. L., González, M. C., Ashton, N. J., Tovar, D., Blanc, F., Pilotto, A., Lemstra, A. W., Paquet, C., Ballard, C. G., Zetterberg, H., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14434 · Cited by 5
Self-citationEvidente, V. G. H., DeKarske, D., Coate, B., & Abler, V. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241228350 · Cited by 5
Clinical utility and research frontiers of neuroimaging in movement disorders
Nobili, F. M., Westman, E., Kogan, R. V., Pereira, J. B., Massa, F., Grazzini, M., Meles, S. K., & Leenders, K. L. (2017) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.17.03018-7 · Cited by 5
Wong, O. W. H., Fung, G. P. C., & Chan, S. S. M. (2019) · Journal of Visualized Experiments · doi:10.3791/60052 · Cited by 5
Jucevičiūtė, N., Balnytė, R., & Laucius, O. (2024) · Medicina · doi:10.3390/medicina60040606 · Cited by 5
Melatonin Treatment of Visual Hallucinations in Parkinson Disease
DeLucca, B., Richardson, R. M., & Stewart, J. T. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000930 · Cited by 5
Yamada, K., Goto, S., Matsuzaki, K., Nagahiro, S., Murase, N., Shimazu, H., Kaji, R., Kuratsu, J., & Ushio, Y. (2006) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2006.00054.x · Cited by 5
Initial treatment of early Parkinson’s disease: A review of recent, randomized controlled trials
Biglan, K., & Holloway, R. G. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0086-7 · Cited by 5
Pulsion severity showed a good correlation with cognitive function in Parkinson’s disease
Kurata, T., Hatanaka, N., Morimoto, N., Deguchi, S., Deguchi, K., Ikeda, Y., & Abe, K. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000384 · Cited by 5
Lange, R., & Erbguth, F. J. (2017) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-017-1284-5 · Cited by 5
Clinical Features of Parkinson Disease
Martin, W. R. W. (2010) · Health care and disease management · doi:10.1002/9783527629480.ch2 · Cited by 5
Psychosis in Parkinson’s disease: unexplained observations in a seemingly simple model
Friedman, J. H., & Akbar, U. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1162713 · Cited by 5
Thomas, G. E. C., Zeidman, P., Sultana, T., Zarkali, A., Razi, A., & Weil, R. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.25.485621 · Cited by 5
Pan, C., Zhao, E., Ren, J., Zhou, G., Wang, Y., Zhang, R., Shen, Y., Liu, W., & Chen, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1685244 · Cited by 3
Samanta, S., Bisht, M., Kanimozhi, M., Kumar, N., & Handu, S. S. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2288_22 · Cited by 4
Brain network connectivity underlying neuropsychiatric symptoms in prodromal Lewy body dementia
Wright, L., Donaghy, P. C., Burn, D. J., Taylor, J., O'Brien, J. T., Yarnall, A. J., Matthews, F. E., Firbank, M., Sigurdsson, H. P., Schumacher, J., et al. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.04.007 · Cited by 4
Unveiling Assessment Gaps in Parkinson's Disease Psychosis: A Scoping Review
Mangone, G., Tosin, M. H. D. S., Goetz, C. G., Stebbins, G. T., & Mestre, T. (2024) · Movement Disorders · doi:10.1002/mds.29710 · Cited by 4
Psychosis in Parkinson’s disease: how should we treat it?
Shotbolt, P., Samuel, M., & David, A. S. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1243 · Cited by 4
Improving care home life for people with Parkinson's
Oates, L. L., Hand, A., Dismore, L. L., Gray, W. K., & Walker, R. W. (2019) · Nursing and Residential Care · doi:10.12968/nrec.2019.21.6.309 · Cited by 4
Recent advancements in ropinirole hydrochloride embedded nano-techniques in Parkinson’s treatment
Katual, M. K., Singh, G., & Harikumar, S. L. (2020) · Panacea Journal of Medical Sciences · doi:10.18231/j.pjms.2019.023 · Cited by 4
The business and practice of psychiatric advanced practice nursing in long term care
Birtley, N. M., & Phillips, L. J. (2020) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2020.07.007 · Cited by 4
Studies on the Bottom-Up and Top-Down Neural Information Flow Alterations in Neurodegeneration
Alipour, A., Mozhdehfarahbakhsh, A., Nouri, S., Petramfar, P., Tahamtan, M., Kamali, A., Rao, K. S. J., & Nami, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200590 · Cited by 4
Lageman, S. K., Donovan, E. K., Villaseñor, T., & Perrin, P. B. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211049146 · Cited by 4
What neurologists wish palliative care physicians knew
Vaughan, C. L., & Bruno, V. A. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85029-2.00005-1 · Cited by 4
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Dutta, R. (2023) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001078 · Cited by 4
Parkinson’s Disease and the Claustrum
Kalaitzakis, M. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404566-8.00012-x · Cited by 4
Benge, J. F., Heemsbergen, T., Nelson, R. A., Konesheck, D. O., Konesheck, B., & Aaron, C. S. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2017.1414884 · Cited by 4
Visual hallucinations in Parkinson’s disease
Аленикова, О. А. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2021121061106 · Cited by 5
Neuropathological Distinctions and Similarities in Movement Disorders with Dementia
Jellinger, K. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-326-2_18 · Cited by 4
The dilemma between milestones of progression versus clinical scales in Parkinson's disease
Greenland, J. C., Camacho, M., & Williams‐Gray, C. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00010-9 · Cited by 3
Desai, A. M., Oluwagbohunmi, A., & Kritzer, M. F. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.115034 · Cited by 3
Ignatavicius, A., Churchill, L., Anderson, J., Konuri, A., O’Callaghan, C., Lewis, S. J. G., & Matar, E. (2025) · Movement Disorders · doi:10.1002/mds.70011 · Cited by 3
Cognitive Deficits in Early Parkinson’s Disease: New Areas of Research
Mason, S., & Barker, R. A. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-011-0003-0 · Cited by 4
The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis
Hermanowicz, N. S., Alva, G., Pagán, F., Espay, A. J., Patel, A., Madrid, K. C., Kremens, D. E., Kenney, J., Arquette, S. M., Tereso, G. J., et al. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.6-b.s2 · Cited by 3
Exploring sexual dysfunction in care homes
Hand, A., & Hill, B. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2021.12.005 · Cited by 3
Fields, J. A., & Tröster, A. I. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.008 · Cited by 3
Fründt, O., Hanff, A.-M. R., Mai, T., Warnecke, T., Wellach, I., Eggers, C., van Munster, M., Dodel, R. C., Kirchner, C., Krüger, R., et al. (2022) · DGNeurologie · doi:10.1007/s42451-022-00459-2 · Cited by 3
Goetz, C. G., & Kompoliti, K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.039 · Cited by 3
Parkinson’s Disease with Dementia
Taylor, J., & O'Brien, J. T. (2012) · Advances in biological psychiatry · doi:10.1159/000331657 · Cited by 4
Presence of freezing and naming abilities in Parkinson’s disease
Albania, G., Pignatti, R., Mauro, A., & Semenza, C. (2010) · Neuropsychological Trends · doi:10.7358/neur-2010-007-alba · Cited by 3
Parkinson’s Disease Psychosis – Prevalence Patterns Across the EU-5
Cook, K., Suresh, R., Lou, K.-J., Kesslak, J. P., & Fredericks, D. (2017) · European Neurological Review · doi:10.17925/enr.2017.12.02.87 · Cited by 3
Treatment Patterns With Antipsychotics in Long-Term Care Patients With Parkinson’s Disease Psychosis
Rashid, N., Shim, A., Andes, S., Quale, S., & Abler, V. (2021) · Journal of Applied Gerontology · doi:10.1177/0733464820987032 · Cited by 3
Sousa, C. S. E., Fabbri, M., Godinho, C., Simões, R. M., Chendo, I., Coelho, M. M., Martins, I. P., & Ferreira, J. J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.652424 · Cited by 3
What are the non-motor symptoms of Parkinson’s disease?
Chaudhuri, К. R., & Quinn, N. P. (2009) · Oxford University Press eBooks · doi:10.1093/med/9780199237234.003.0001 · Cited by 3
Diagnosis and Treatment of Hallucinations and Delusions in Parkinson's Disease
Aarsland, D., & Larsen, J. P. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-326-2_28 · Cited by 3
Self-citationCognitive profile of patients with and without speech impairment in Parkinson's disease
Sousa, N. M. F., Diniz, J. D. F. G., Galvão, A. P., & Brucki, S. M. D. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-0093 · Cited by 2
Rajagopalan, K., Gopal, D., Chrones, L., Doshi, D., & Rashid, N. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2487358 · Cited by 2
Metadata
- Authors
- Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
- Affiliations
- Stavanger University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Aarsland, Dag
- ORCID
- Aarsland, Dag
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 48
- Issue
- 8
- Pages
- 938-942
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2083220625
- Cited by
- 811
- References
- 21
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Journal of the American Geriatrics Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review